Analyst Price Target is $83.50
▲ +17.06% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Apollo Medical in the last 3 months. The average price target is $83.50, with a high forecast of $92.00 and a low forecast of $75.00. The average price target represents a 17.06% upside from the last price of $71.33.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in Apollo Medical.
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It focuses on providing population health management and healthcare delivery platform. The company operates as an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.